These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Action of melatonin on squamous cell carcinoma and other tumors of the oral cavity (Review). Cutando A; López-Valverde A; DE Vicente J; Gimenez JL; Carcía IA; DE Diego RG Oncol Lett; 2014 Apr; 7(4):923-926. PubMed ID: 24944644 [TBL] [Abstract][Full Text] [Related]
6. A Review on Melatonin's Effects in Cancer: Potential Mechanisms. Hanikoglu A; Kucuksayan E; Akduman RC; Ozben T Anticancer Agents Med Chem; 2018; 18(7):985-992. PubMed ID: 29173185 [TBL] [Abstract][Full Text] [Related]
8. Luzindole but not 4-phenyl-2- propionamidotetralin (4P-PDOT) diminishes the inhibitory effect of melatonin on murine Colon 38 cancer growth in vitro. Winczyk K; Fuss-Chmielewska J; Lawnicka H; Pawlikowski M; Karasek M Neuro Endocrinol Lett; 2009; 30(5):657-62. PubMed ID: 20035258 [TBL] [Abstract][Full Text] [Related]
9. Melatonin as a negative mitogenic hormonal regulator of human prostate epithelial cell growth: potential mechanisms and clinical significance. Tam CW; Chan KW; Liu VW; Pang B; Yao KM; Shiu SY J Pineal Res; 2008 Nov; 45(4):403-12. PubMed ID: 18637986 [TBL] [Abstract][Full Text] [Related]
10. Effects of melatonin and melatonin receptors ligand N-[(4-methoxy-1H-indol-2-yl)methyl]propanamide on murine Colon 38 cancer growth in vitro and in vivo. Winczyk K; Pawlikowski M; Lawnicka H; Kunert-Radek J; Spadoni G; Tarzia G; Karasek M Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():50-4. PubMed ID: 12019352 [TBL] [Abstract][Full Text] [Related]
11. Growth-inhibitory activity of melatonin on murine foregastric carcinoma cells in vitro and the underlying molecular mechanism. Xu L; Liu H; Zhang H; Wang RX; Song J; Zhou RX Anat Rec (Hoboken); 2013 Jun; 296(6):914-20. PubMed ID: 23564716 [TBL] [Abstract][Full Text] [Related]
12. Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways. Pandi-Perumal SR; Trakht I; Srinivasan V; Spence DW; Maestroni GJ; Zisapel N; Cardinali DP Prog Neurobiol; 2008 Jul; 85(3):335-53. PubMed ID: 18571301 [TBL] [Abstract][Full Text] [Related]
13. Melatonin and its role in oxidative stress related diseases of oral cavity. Czesnikiewicz-Guzik M; Konturek SJ; Loster B; Wisniewska G; Majewski S J Physiol Pharmacol; 2007 Aug; 58 Suppl 3():5-19. PubMed ID: 17901579 [TBL] [Abstract][Full Text] [Related]
15. Localization and biological activities of melatonin in intact and diseased gastrointestinal tract (GIT). Konturek SJ; Konturek PC; Brzozowska I; Pawlik M; Sliwowski Z; Cześnikiewicz-Guzik M; Kwiecień S; Brzozowski T; Bubenik GA; Pawlik WW J Physiol Pharmacol; 2007 Sep; 58(3):381-405. PubMed ID: 17928638 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic actions of melatonin in cancer: possible mechanisms. Srinivasan V; Spence DW; Pandi-Perumal SR; Trakht I; Cardinali DP Integr Cancer Ther; 2008 Sep; 7(3):189-203. PubMed ID: 18815150 [TBL] [Abstract][Full Text] [Related]
17. [Effects of melatonin on circadian time keeping system]. Mishima K; Okawa M Nihon Rinsho; 1998 Feb; 56(2):302-7. PubMed ID: 9503826 [TBL] [Abstract][Full Text] [Related]
18. Circadian stage-dependent inhibition of human breast cancer metabolism and growth by the nocturnal melatonin signal: consequences of its disruption by light at night in rats and women. Blask DE; Dauchy RT; Brainard GC; Hanifin JP Integr Cancer Ther; 2009 Dec; 8(4):347-53. PubMed ID: 20042410 [TBL] [Abstract][Full Text] [Related]
19. Melatonin. Mor M; Plazzi PV; Spadoni G; Tarzia G Curr Med Chem; 1999 Jun; 6(6):501-18. PubMed ID: 10213796 [TBL] [Abstract][Full Text] [Related]
20. Age-related decline in melatonin and its MT1 receptor are associated with decreased sensitivity to melatonin and enhanced mammary tumor growth. Hill SM; Cheng C; Yuan L; Mao L; Jockers R; Dauchy B; Blask DE Curr Aging Sci; 2013 Feb; 6(1):125-33. PubMed ID: 23895529 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]